Bavarian Nordic A/S (BVNRY)
OTCMKTS
· Delayed Price · Currency is USD
7.36
-0.17 (-2.26%)
Apr 22, 2025, 2:05 PM EDT
Bavarian Nordic Revenue
In the year 2024, Bavarian Nordic had annual revenue of 5.72B DKK, down -19.06%. Bavarian Nordic had revenue of 2.09B in the quarter ending December 31, 2024, a decrease of -14.44%.
Revenue
5.72B DKK
Revenue Growth
-19.06%
P/S Ratio
2.19
Revenue / Employee
3.56M DKK
Employees
1,605
Market Cap
1.74B USD
Revenue Chart
* This company reports financials in DKK.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 5.72B | -1.35B | -19.06% |
| Dec 31, 2023 | 7.06B | 3.91B | 124.14% |
| Dec 31, 2022 | 3.15B | 1.25B | 66.02% |
| Dec 31, 2021 | 1.90B | 45.49M | 2.46% |
| Dec 31, 2020 | 1.85B | 1.19B | 179.61% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| SS Innovations International | 20.65M |
| Endo Inc. | 1.76B |
| Veradigm | 588.02M |
| Northwest Biotherapeutics | 1.38M |
| Elite Pharmaceuticals | 70.00M |
| Glass House Brands | 200.90M |
| BioStem Technologies | 301.83M |
| American Oncology Network | 1.76B |
Bavarian Nordic News
- 6 days ago - Bavarian Nordic's Chikungunya Vaccine Receives Recommendation from U.S. CDC's Advisory Committee on Immunization Practices (ACIP) - GlobeNewsWire
- 13 days ago - Correction: Resolutions of the Annual General Meeting 2025 of Bavarian Nordic A/S - GlobeNewsWire
- 13 days ago - Resolutions of the Annual General Meeting 2025 of Bavarian Nordic A/S - GlobeNewsWire
- 15 days ago - Bavarian Nordic Trading At Great Value Levels With Upbeat 2025 Outlook - Seeking Alpha
- 19 days ago - Pharma tariff relief likely short-lived with sector-specific duties on the horizon - CNBC
- 22 days ago - US FDA approves freeze-dried version of Bavarian Nordic's mpox, smallpox vaccine - Reuters
- 22 days ago - Bavarian Nordic Receives U.S. FDA Approval of Freeze-Dried Smallpox and Mpox Vaccine - GlobeNewsWire
- 5 weeks ago - Widely used drugs on US imports list from Europe - Reuters